Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

757 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Development of a Kidney Prognostic Score in a Japanese Cohort of Patients With Antineutrophil Cytoplasmic Autoantibody Vasculitis.
Takeda R, Takahashi K, Kronbichler A, Akiyama D, Hanai S, Kobayashi Y, Matsuki A, Umibe T, Ito C, Sugimoto T, Sugiyama T, Yoshida S, Nishio Y, Nukui I, Nakashima A, Wakabayashi H, Asanuma K, Furuta S, Nakajima H, Nakagomi D. Takeda R, et al. Among authors: furuta s. Kidney Int Rep. 2024 Jan 8;9(3):611-623. doi: 10.1016/j.ekir.2024.01.007. eCollection 2024 Mar. Kidney Int Rep. 2024. PMID: 38481514 Free PMC article.
Benralizumab versus Mepolizumab for Eosinophilic Granulomatosis with Polyangiitis.
Wechsler ME, Nair P, Terrier B, Walz B, Bourdin A, Jayne DRW, Jackson DJ, Roufosse F, Börjesson Sjö L, Fan Y, Jison M, McCrae C, Necander S, Shavit A, Walton C, Merkel PA; MANDARA Study Group. Wechsler ME, et al. N Engl J Med. 2024 Mar 7;390(10):911-921. doi: 10.1056/NEJMoa2311155. Epub 2024 Feb 23. N Engl J Med. 2024. PMID: 38393328 Clinical Trial.
Clinical Characteristics and Outcomes of Polyarteritis Nodosa: An International Study.
Karadag O, Bolek EC, Ayan G, Mohammad AJ, Grayson PC, Pagnoux C, Martín-Nares E, Monti S, Abe Y, Alberici F, Alibaz-Oner F, Cuthbertson D, Dagna L, Direskeneli H, Khalidi NA, Koening C, Langford CA, McAlear CA, Monach PA, Moroni L, Padoan R, Seo P, Warrington KJ, Hocevar A, Hinojosa-Azaola A, Furuta S, Emmi G, Ozen S, Jayne D, Merkel PA; GLOBAL-PAN Collaborators. Karadag O, et al. Among authors: furuta s. Arthritis Rheumatol. 2024 Feb 12. doi: 10.1002/art.42817. Online ahead of print. Arthritis Rheumatol. 2024. PMID: 38343337
Short-term and long-term outcomes of patients with anti-melanoma differentiation-associated gene 5 antibody-positive dermatomyositis.
Ida T, Furuta S, Fujiwara M, Hiraguri M, Hirose K, Ikeda K, Iwamoto T, Kagami SI, Kobayashi Y, Kurasawa K, Nakagomi D, Oya Y, Sanayama Y, Shimizu T, Tamachi T, Umibe T, Yasui M, Nakajima H. Ida T, et al. Among authors: furuta s. Rheumatology (Oxford). 2024 Jan 12:keae011. doi: 10.1093/rheumatology/keae011. Online ahead of print. Rheumatology (Oxford). 2024. PMID: 38216799
Association of Contrast Extravasation Grade With Massive Transfusion in Pediatric Blunt Liver and Spleen Injuries: A Multicenter Retrospective Cohort Study.
Katsura M, Fukuma S, Kuriyama A, Kondo Y, Yasuda H, Matsushima K, Shiraishi A, Kusaka A, Nakabayashi Y, Yagi M, Ito F, Tanikawa A, Kushimoto S; SHIPPs Study Group. Katsura M, et al. J Pediatr Surg. 2024 Mar;59(3):500-508. doi: 10.1016/j.jpedsurg.2023.10.069. Epub 2023 Nov 4. J Pediatr Surg. 2024. PMID: 37996348
Reduced-dose versus high-dose glucocorticoids added to rituximab on remission induction in ANCA-associated vasculitis: predefined 2-year follow-up study.
Furuta S, Nakagomi D, Kobayashi Y, Hiraguri M, Sugiyama T, Amano K, Umibe T, Kono H, Kurasawa K, Kita Y, Matsumura R, Kaneko Y, Ninagawa K, Hiromura K, Kagami SI, Inaba Y, Hanaoka H, Ikeda K, Nakajima H; LoVAS collaborators. Furuta S, et al. Ann Rheum Dis. 2024 Jan 2;83(1):96-102. doi: 10.1136/ard-2023-224343. Ann Rheum Dis. 2024. PMID: 37734880 Clinical Trial.
757 results